Analyst Price Targets — QTRX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 22, 2025 12:00 pm | — | Canaccord Genuity | $8.00 | $6.59 | TheFly | Quanterix price target raised to $8 from $5 at Canaccord |
| March 25, 2025 1:35 pm | Sung Ji Nam | Scotiabank | $18.00 | $7.02 | TheFly | Quanterix price target lowered to $18 from $28 at Scotiabank |
| June 11, 2024 7:54 am | Sung Niam | Scotiabank | $32.00 | $18.50 | StreetInsider | Scotiabank Reiterates Sector Outperform Rating on Quanterix Corp. (QTRX) |
| May 8, 2024 1:42 pm | Kyle Mikson | Canaccord Genuity | $25.00 | $16.51 | TheFly | Quanterix growth potential not reflected in shares, says Canaccord |
| November 10, 2022 10:12 am | — | Goldman Sachs | $13.00 | $11.72 | Benzinga | Goldman Sachs Maintains Neutral on Quanterix, Lowers Price Target to $13 |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for QTRX

Aberdeen Group plc reduced its position in shares of Quanterix Corporation (NASDAQ: QTRX) by 81.6% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 104,039 shares of the company's stock after selling 460,542 shares during the quarter. Aberdeen Group plc owned about

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection (the “Company”), today announced that the Company's 2026 annual meeting of shareholders (the “Annual Meeting”) will be held virtually, by means of remote communication, on Tuesday, June 9, 2026 at 10:00 am Eastern Time. Stockholders of record of the Company's…

Quanterix (NASDAQ: QTRX - Get Free Report) and IM Cannabis (NASDAQ: IMCC - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations and risk. Institutional and Insider Ownership 86.5% of Quanterix shares

TREES (OTCMKTS:CANN - Get Free Report) and Quanterix (NASDAQ: QTRX - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, valuation, earnings, risk, analyst recommendations and profitability. Profitability This table compares TREES and Quanterix's net margins,

Quanterix Corporation (QTRX) Q4 2025 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for QTRX.
U.S. House Trading
No House trades found for QTRX.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
